Publicacións nas que colabora con Pablo Piñón Esteban (13)

2024

  1. lncRNA CDKN2B-AS1 is downregulated in patients with ventricular fibrillation in acute myocardial infarction

    PLoS ONE, Vol. 19, Núm. 5 May

2021

  1. Economic evaluation of complete revascularization versus stress echocardiography-guided revascularization in the STEACS with multivessel disease

    Revista Espanola de Cardiologia, Vol. 74, Núm. 12, pp. 1055-1062

  2. Light chain and transthyretin cardiac amyloidosis: Clinical characteristics, natural history and prognostic factors

    Medicina Clinica, Vol. 156, Núm. 8, pp. 369-378

2020

  1. Impact on mortality after implementation of a network for ST-segment elevation myocardial infarction care. The IPHENAMIC study

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 632-642

  2. Presence of bacterial DNA in thrombotic material of patients with myocardial infarction

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Angiographically Guided Complete Revascularization Versus Selective Stress Echocardiography-Guided Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease: The CROSS-AMI Randomized Clinical Trial

    Circulation: Cardiovascular Interventions, Vol. 12, Núm. 10

2010

  1. Prevalencia, causas y pronóstico de las «falsas alarmas» al laboratorio de hemodinámica en pacientes con sospecha de infarto de miocardio con elevación del segmento ST

    Revista Espanola de Cardiologia, Vol. 63, Núm. 5, pp. 518-527

2008

  1. Quinolone-related Achilles Tendinopathy in Heart Transplant Patients: Incidence and Risk Factors

    Journal of Heart and Lung Transplantation, Vol. 27, Núm. 1, pp. 46-51

2007

  1. Bone Fractures After Cardiac Transplantation

    Transplantation Proceedings, Vol. 39, Núm. 7, pp. 2393-2396

2006

  1. Mutaciones en el gen de la cadena pesada de la betamiosina en pacientes con miocardiopatía hipertrófica

    Revista Espanola de Cardiologia, Vol. 59, Núm. 10, pp. 1008-1018

2005

  1. Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): Incidence, management, and the value of C4d for diagnosis

    American Journal of Transplantation, Vol. 5, Núm. 10, pp. 2560-2564

  2. Long-term results of heart transplant in recipients older and younger than 65 years: A comparative study of mortality, rejections, and neoplasia in a cohort of 445 patients

    Transplantation Proceedings

  3. Safety of statins when response is carefully monitored: A study of 336 heart recipients

    Transplantation Proceedings